UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3774) 3774
Book Chapter (53) 53
Newspaper Article (35) 35
Magazine Article (30) 30
Newsletter (29) 29
Web Resource (8) 8
Government Document (4) 4
Book / eBook (3) 3
Dissertation (3) 3
Publication (2) 2
Conference Proceeding (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2737) 2737
science & technology (2642) 2642
life sciences & biomedicine (2595) 2595
naltrexone - therapeutic use (2302) 2302
male (1898) 1898
naltrexone (1805) 1805
narcotic antagonists - therapeutic use (1444) 1444
female (1361) 1361
adult (1219) 1219
animals (943) 943
pharmacology & pharmacy (890) 890
psychiatry (887) 887
naltrexone - pharmacology (817) 817
naltrexone - analogs & derivatives (758) 758
middle aged (746) 746
substance abuse (744) 744
naltrexone - administration & dosage (683) 683
alcoholism - drug therapy (619) 619
treatment outcome (610) 610
neurosciences & neurology (594) 594
neurosciences (554) 554
narcotic antagonists - pharmacology (531) 531
pharmacotherapy (493) 493
narcotic antagonists - administration & dosage (459) 459
alcoholism (455) 455
naltrexone - adverse effects (441) 441
rats (440) 440
dependency (415) 415
double-blind method (415) 415
alcohol use (414) 414
care and treatment (412) 412
dose-response relationship, drug (412) 412
opioids (392) 392
drug therapy (391) 391
narcotics (356) 356
alcohol deterrents - therapeutic use (313) 313
adolescent (298) 298
social sciences (295) 295
psychology (290) 290
abridged index medicus (288) 288
substance abuse treatment (287) 287
opioid-related disorders - drug therapy (286) 286
narcotic antagonists - adverse effects (267) 267
analysis (264) 264
drug use (263) 263
research (262) 262
usa (261) 261
mice (257) 257
time factors (250) 250
clinical trials (249) 249
general & internal medicine (242) 242
taurine - analogs & derivatives (229) 229
alcohol (228) 228
drug abuse (227) 227
medicine, general & internal (225) 225
clinical neurology (221) 221
drug therapy, combination (221) 221
aged (219) 219
heroin (219) 219
methadone - therapeutic use (217) 217
taurine - therapeutic use (217) 217
treatment (217) 217
buprenorphine (209) 209
young adult (207) 207
opioid-related disorders - rehabilitation (194) 194
methadone (192) 192
analgesics, opioid - adverse effects (189) 189
alcoholism - psychology (187) 187
dosage and administration (185) 185
rats, sprague-dawley (179) 179
acamprosate (176) 176
combined modality therapy (176) 176
morphine (176) 176
psychology, clinical (175) 175
buprenorphine - therapeutic use (169) 169
health aspects (169) 169
pharmacology (166) 166
randomized controlled trials as topic (161) 161
pharmacology/toxicology (160) 160
disease models, animal (159) 159
heroin dependence - rehabilitation (158) 158
analgesics, opioid - therapeutic use (153) 153
drugs (150) 150
naloxone (149) 149
delayed-action preparations (147) 147
opioid receptors (146) 146
patient compliance (146) 146
united states (145) 145
alcoholism - rehabilitation (141) 141
clinical trials as topic (140) 140
naloxone - therapeutic use (140) 140
usage (140) 140
disulfiram - therapeutic use (139) 139
alcohol drinking - drug therapy (138) 138
morphine - pharmacology (138) 138
treatment outcomes (138) 138
alcohol dependence (137) 137
follow-up studies (137) 137
administration, oral (136) 136
addiction (135) 135
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3812) 3812
Spanish (37) 37
German (33) 33
French (30) 30
Russian (14) 14
Italian (10) 10
Japanese (8) 8
Norwegian (8) 8
Danish (5) 5
Chinese (4) 4
Dutch (4) 4
Polish (4) 4
Swedish (4) 4
Czech (3) 3
Finnish (3) 3
Hebrew (2) 2
Hungarian (2) 2
Portuguese (2) 2
Lithuanian (1) 1
Serbian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2004, Volume 18, Issue 14, 22
..., with onset in the first 3 years of life. As part of a multimodal approach that includes educational and behavioural interventions, appropriate use of pharmacotherapy in patients with PDDs can improve some symptoms and behaviours... 
Citalopram, therapeutic use | Clozapine, therapeutic use | Venlafaxine, therapeutic use | Amantadine, therapeutic use | Buspirone, therapeutic use | Ziprasidone, therapeutic use | Fluoxetine, therapeutic use | Pyridoxine, therapeutic use | Antipsychotics, therapeutic use | Valproate semisodium, therapeutic use | Naltrexone, therapeutic use | Niaprazine, therapeutic use | Clonidine, therapeutic use | Antidepressants, therapeutic use | Secretin, therapeutic use | Olanzapine, therapeutic use | Quetiapine, therapeutic use | Sertraline, therapeutic use | Lithium, therapeutic use | Paroxetine, therapeutic use | Mirtazapine, therapeutic use | Clomipramine, therapeutic use | Pervasive developmental disorders, treatment | Guanfacine, therapeutic use | Methylphenidate, therapeutic use | Fluvoxamine, therapeutic use | Risperidone, therapeutic use | Lamotrigine, therapeutic use | Pharmacotherapy | Neurology | Neurosciences | Medicine & Public Health | Psychiatry | Psychopharmacology | Pharmacology & Pharmacy | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Psychotropic Drugs - adverse effects | Developmental Disabilities - drug therapy | Antipsychotic Agents - therapeutic use | Antipsychotic Agents - adverse effects | Humans | Adolescent | Serotonin Uptake Inhibitors - therapeutic use | Serotonin Uptake Inhibitors - adverse effects | Clinical Trials as Topic | Child | Developmental Disabilities - psychology | Psychotropic Drugs - therapeutic use | Index Medicus
Book Review
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 06/2018, Volume 2018, Issue 6, pp. CD006332 - CD006332
Background Opioid‐induced bowel dysfunction (OIBD) is characterised by constipation, incomplete evacuation, bloating, and gastric reflux. It is one of the... 
Quaternary Ammonium Compounds | Intestinal Diseases | Oxycodone | Receptors, Opioid, mu | Palliative Care | Palliative and supportive care | Naltrexone | Gastrointestinal | 2019 4. Palliative, supportive, frailty | Nalbuphine | Neoplasms | Randomized Controlled Trials as Topic | Narcotic Antagonists | Symptomatic relief | Naloxone | Piperidines | Child health | Opioid‐Related Disorders | Medicine General & Introductory Medical Sciences | Palliative & other supportive care | Constipation | Defecation | Gastrointestinal Agents | Cancer | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Naltrexone - analogs & derivatives | Naltrexone - therapeutic use | Opioid-Related Disorders - drug therapy | Intestinal Diseases - chemically induced | Humans | Male | Neoplasms - complications | Nalbuphine - therapeutic use | Female | Constipation - drug therapy | Oxycodone - adverse effects | Oxycodone - therapeutic use | Defecation - drug effects | Quaternary Ammonium Compounds - therapeutic use | Intestinal Diseases - drug therapy | Narcotic Antagonists - adverse effects | Naloxone - therapeutic use | Receptors, Opioid, mu - antagonists & inhibitors | Constipation - chemically induced | Narcotic Antagonists - therapeutic use | Piperidines - therapeutic use | Naloxone - adverse effects | Gastrointestinal Agents - therapeutic use | Naltrexone - adverse effects | Index Medicus
Journal Article